MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

HealthDay 13 August at 03.52 PM

Nicotine Analogue Concentrations Deviate From Labels


TUESDAY, Aug. 13, 2024 (HealthDay News) -- There are discrepancies between labeled and measured concentrations of nicotine analogues in electronic cigarettes and e-cigarette liquids, according to a research letter published online Aug. 7 in the Journal of the American Medical Association.

Hanno C. Erythropel, Ph.D., from Yale University in New Haven, Connecticut, and colleagues quantified constituents of e-cigarette products containing nicotine analogues to assess product consistency. The analysis included nine available flavors of product 1 labeled as containing 5 percent 6-methylnicotine (6MN) and two flavors of product 2 at four concentrations of nicotinamide (0, 12, 24, and 36 mg/mL) that were purchased between November 2023 and February 2024 from three major online retailers.

The researchers found that 6MN presence was confirmed in all product 1 flavors. Both nicotinamide and 6MN were detected in product 2 samples labeled as containing nicotinamide (six of eight). No sample contained nicotine. Product 1 was labeled as containing 5 percent 6MN (50 mg/g), but the analysis showed it only contained 5.8 to 6.3 mg/g (87 to 88 percent less than labeled). In product 2, samples contained nicotinamide contents 7 to 46 percent less than as labeled. Although product 2 labels did not list 6MN as an ingredient, 6MN was detected (0.06 to 0.17 mg/g) when nicotinamide was present. Product 1 samples contained only the (S)-6MN stereoisomer, which previous research showed is more potent and addictive than the (R) form. Product 1 samples all contained the artificial sweetener neotame (0.20 to 0.86 mg/g) and the synthetic coolant 2-isopropyl-N-2,3-trimethylbutyramide (WS-23; 4.34 to 16.39 mg/g) plus various flavorants, whereas product 2 samples did not contain sweeteners or coolants.

"With e-cigarettes increasingly considered for smoking cessation, the advent of nicotine analogue-containing products with unknown health risks raises concern," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)


Recent Comments


  • avatar